【公司动态】ACROBiosystems与CMP达成为平台提供生物制药领域样品质谱分析服务的战略合作

BROOKLYN, NY – June 08, 2018 – ACROBiosystems and CMP Scientific today announced that the companies have entered into a strategic collaboration in CE-MS sample analysis services. The companies will co-develop monoclonal antibody charge variants sample analysis services and explore the feasibility of integrated workflow using the recombinant protein ligands from ACROBiosystems for biotherapeutics in vivo pharmacokinetic and drug metabolism analysis using CMP Scientific’s EMASS-II CE-MS technology.

美国纽约市布鲁克林区 – 2018年6月8号 – ACROBiosystems公司和美国CMP质谱科技公司今天宣布双方正式开展以毛细管电泳与质谱联用技术提供样品分析服务的战略合作。ACROBiosystems和CMP将共同开发单克隆抗体药物电荷异质性分析的样品分析服务，并探索在CMP公司独有的EMASS-II新型CE-MS联用技术基础上，使用ACROBiosystems公司提供的重组蛋白试剂，建立完整的生物大分子药物在体内的生物转化、药物代谢和药代动力学样品分析服务的商业可行性。

The EMASS-II CE-MS interface was introduced by CMP Scientific in 2015 and has been adopted by many leading biopharmaceuticals companies for a variety of applications including monoclonal antibody (mAb) intact mass analysis, impurity profiling, charge variants characterization, subunit analysis, peptide mapping, biosimilar comparisons and biotransformation studies.  This interface is also being used at several life science research institutes around the world for metabolite analysis, nucleic acid analysis and polysaccharide analysis.

自2015年由美国CMP质谱科技公司研制成功进入市场后，EMASS-II型CE-MS联用接口技术已经被众多世界领先的生物制药公司应用到单克隆抗体药物的整体分子分析、纯度分析、电荷异质性表征、亚基分析、蛋白序列鉴定、生物仿制药比对、以及生物药的体内转化等方面。EMASS-II型CE-MS联用接口也被全球多家生命科学研究单位用于代谢物、核酸药物、以及多糖药物分析。

"Our collaboration with CMP Scientific leverages ACROBiosystems’ leadership in recombinant protein production and expands our capabilities in product characterization utilizing CMP’s advanced CE-MS technology," said Mike Chen, Founder and CEO of ACROBiosystems. "Through this collaboration, we are poised to provide our global biopharma clients CE-MS based methods development and value-added services.”

“为了充分发挥ACROBiosystems公司在重组蛋白生产的领先优势，我们与CMP质谱科技公司的战略合作可以在CMP公司先进的CE-MS联用技术的基础上提升我们在产品分析表征上的竞争力”，ACROBiosystems公司的创始人和首席执行官陈宜顶说到，“通过与CMP的紧密合作，我们将做好准备为我们全球的生物制药用户提供基于新型CE-MS联用技术的分析方法开发和产品增值服务”。

“ACROBiosystems is well recognized in the biopharma industry for its quality of recombinant protein products and services.” said James Xia, CEO of CMP Scientific.  “By utilizing CMP’s advanced CE-MS technology platform, ACROBiosystems will be able to offer its biopharma customers analytical services to help solve many of the analytical challenges faced by biopharma researchers.”

“ACROBiosystems公司因其提供的高质量的重组蛋白产品和服务在全球的生物制药行业中受到了广泛的好评”，CMP公司首席执行官夏强为说到，“通过使用CMP公司先进的CE-MS联用技术平台，ACROBiosystems将能够给全世界的生物制药用户提供样品质谱分析服务，从而帮助解决生物制药研究人员面临的众多分析检测的挑战”。

About ACROBiosystems: ACROBiosystems is an internationally recognized manufacturer of recombinant proteins committed to supporting pharmaceutical industry. Its high-quality proteins have been widely used in the process of therapeutic drug development from immunization, antibody screening, to pre-clinical and clinical assay development. The introduction of the Innovation Lab Delaware Innovation Space in Wilmington Delaware provides the right blend of innovation and technology and valued-added services that utilize a variety of platform technologies.

关于ACROBiosystems公司：ACROBiosystems公司是国际认可的聚焦于生物制药领域的重组蛋白试剂生产商。其高质量的重组蛋白产品已经被广泛应用于治疗性药物从免疫接种、抗体筛选到临床前和临床阶段的方法开发的各个药物研发阶段。ACROBiosystems公司近期在美国特拉华州维明顿市成立的创新实验室提供了创新、科技、以及产品增值服务的多种平台技术的融合。

About CMP Scientific Corp: CMP Scientific is a global analytical instrument company with advanced, proprietary Capillary Electrophoresis – Mass Spectrometry (CE-MS) technologies. CMP Scientific develops and markets CE-MS ion sources for ESI mass spectrometers and provides applications, consumables and method development services to help researchers utilize CE-MS to solve many challenging analytical problems.

关于美国CMP质谱科技公司: 美国CMP质谱科技公司是一家拥有世界领先、专利保护的毛细管电泳与质谱联用技术的面向全球的分析仪器公司。美国CMP质谱科技公司研制、生产和销售使用在电喷雾质谱上的CE-MS联用离子源，并且提供应用方法、相关耗材、以及方法开发服务以帮助全球范围的科研人员使用CE-MS技术来解决众多的极具挑战的分析问题。